RSLS Stock Price, Chart, Stats & News

ReShape Lifesciences Inc.
Save
2.34M
Market cap
–
Current P/E
–
Forward P/E
RSLS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 68.43% |
Operating margin | -3259.05% |
Pretax margin | -2890.40% |
Net margin | -2897.28% |
Effective tax rate | -0.24% |
ROA | -142.57% |
ROE | -277.53% |
D/E | 0.01x |
Interest coverage ratio | -61.80x |
RSLS valuation
P/E | – |
P/S | 7.31x |
P/B | 0.26x |
P/CF | -0.12x |
P/FCF | -0.29x |
P/OCF | -0.12x |
PEG | -0.00x |
EV multiple | -0.59x |
About
Founded in 2002 and based in San Clemente, California, ReShape Lifesciences Inc. operates as a medical device company dedicated to addressing obesity and metabolic diseases. The company's market extends throughout the United States, Australia, Europe, and globally. Its diverse product lineup features the Lap-Band System, a minimally invasive, long-term solution for severe obesity that offers an alternative to more extensive surgical interventions like gastric bypass or sleeve gastrectomy.
Similar securities
Based on sector and market capitalization
Report issue











